AIDS and HIV Vaccine

Mucosal Administration Can Improve Vaccine Efficacy

Published in AIDS Weekly, January 28th, 2002

by Michael Greer, senior medical writer - Mucosal administration of HIV vaccines can improve the protection they offer, researchers in the United States report.

Igor M. Belyakov and colleagues at the National Institutes of Health in Bethesda, Maryland, the Wisconsin Regional Primate Center in Madison, Wisconsin, the Emory University Vaccine Center in Atlanta, Tulane University in New Orleans, Epimmune, Inc., in San Diego, and Advanced BioScience Laboratories, Inc., in Kensington, Maryland, evaluated the effect of delivery route on the efficacy of HIV vaccines.

They found that mucosal administration enhanced the potency of vaccine-induced antiviral...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (2002-01-28)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry